Q32 BIO INC COM is a security (CUSIP 746964105) tracked across SEC portfolio filings. 55 institutional managers reported $59.6M on Form 13F as of 2026-06-30; 4 registered fund positions totaling $778K via N-PORT as of 2026-05-29.
Showing 15 of 55 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| ORBIMED ADVISORS LLC | New York, NY | $14.5M | 2,252,987 |
| Atlas Venture Life Science Advisors, LLC | Cambridge, MA | $13.4M | 2,092,106 |
| Opaleye Management Inc. | Boston, MA | $8.1M | 1,256,228 |
| Carlyle Group Inc. | WASHINGTON, DC | $7.1M | 1,102,741 |
| Sanofi | Paris, I0 | $3.1M | 244,083 |
| ARCH Venture Management, LLC | CHICAGO, IL | $2.1M | 320,482 |
| ACORN CAPITAL ADVISORS, LLC | NEW YORK, NY | $2.0M | 315,052 |
| MACKENZIE FINANCIAL CORP | TORONTO ONTARIO, A6 | $1.6M | 246,304 |
| RENAISSANCE TECHNOLOGIES LLC | NEW YORK, NY | $1.3M | 206,915 |
| VANGUARD GROUP INC | Valley Forge, PA | $1.1M | 321,051 |
| MONIMUS CAPITAL MANAGEMENT, LP | WOODBRIDGE, NJ | $862K | 134,310 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $759K | 118,152 |
| Pfizer Inc | New York, NY | $737K | 101,618 |
| BlackRock, Inc. | New York, NY | $553K | 86,147 |
| JANE STREET GROUP, LLC | NEW YORK, NY | $421K | 65,599 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $768K | 0.09% |
| U.S. MICRO CAP PORTFOLIO | DFA INVESTMENT DIMENSIONS GROUP INC | $10K | 0.01% |
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $144 | 0.00% |
| Blackstone Alternative Multi-Strategy Fund | Blackstone Alternative Investment Funds | $45 | 0.00% |